Back to Search

JONATHAN MEYER, M.D.

M.D.

Psychiatry Physician

NPI: 1003832809Individual

Specialties, Licenses & Credentials

Psychiatry PhysicianPrimary

Psychiatry & Neurology — Psychiatry

Code: 2084P0800X

G066836(CA)

Clinical Trials (4)

4
Linked Trials
0
Recruiting
2
With Results

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

NCT00338949COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Examining the Effects of Antipsychotic Medications on Insulin Sensitivity

NCT00895921COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics

NCT01411930COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study

NCT00167817COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.
PMID 16137860·Schizophr Res·2005
4-observational
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
PMID 19640511·Biol Psychiatry·2009
3-trial
The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.
PMID 19192469·J Clin Psychiatry·2009
4-observational
The metabolic syndrome and schizophrenia.
PMID 19133915·Acta Psychiatr Scand·2009
6-review
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.
PMID 18534821·Schizophr Res·2008
3-trial
Sexual dysfunction in patients treated with atypical antipsychotics.
PMID 19026271·J Clin Psychiatry·2008
5-case
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.
PMID 18258416·Schizophr Res·2008
3-trial
Antipsychotic safety and efficacy concerns.
PMID 18284274·J Clin Psychiatry·2007
6-review
Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial.
PMID 17286525·J Clin Psychiatry·2007
8-other
Drug-drug interactions with antipsychotics.
PMID 18389925·CNS Spectr·2007
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3350 LA JOLLA VILLAGE DR, 116-A
SAN DIEGO, CA 92161

Quick Facts

NPI
1003832809
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Clinical Trials
4
Publications
20

Are you this provider?

Claim Your Profile